Cargando…
可手术的局部晚期非小细胞肺癌的新希望：新辅助免疫治疗
Immune checkpoint inhibitor (ICI) has been proven to be a major breakthrough in patients with advanced non-small cell lung cancer. Up to now, neoadjuvant therapy using ICI are rare. However, in the context of cancer immunotherapy, neoadjuvant treatment may offer an extra advantage. In this review, w...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007393/ https://www.ncbi.nlm.nih.gov/pubmed/31948539 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.01.09 |